Metagenomi, Inc.
A genetic medicines company developing therapeutics with a genome editing toolbox.
MGX | US
Overview
Corporate Details
- ISIN(s):
- US59102M1045
- LEI:
- Country:
- United States of America
- Address:
- 5959 HORTON STREET, 94608 EMERYVILLE
- Website:
- https://metagenomi.co/
Description
Metagenomi, Inc. is a genetic medicines company that develops curative therapeutics using its proprietary genome editing toolbox. The company's approach is founded on metagenomics, the study of genetic material recovered from natural environments, to discover and engineer novel gene editing systems. Its wholly-owned toolbox is designed to be capable of correcting various types of genetic mutations through site-specific deletion, integration, and correction. Metagenomi leverages high-throughput screening and AI-based cloud computing to expand its portfolio of editing technologies, focusing on disease indications with well-understood biology and clear clinical development pathways.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Metagenomi, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Metagenomi, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Metagenomi, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
